Current Cancer Therapy Reviews

Editor-in-Chief

Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:13   Issue: 1
Pp: 1-1
John F. Deeken
DOI: 10.2174/157339471301170829115741



Preface free to download

Volume:13   Issue: 1
Pp: 2-2
Kurt S. Zaenker
DOI: 10.2174/157339471301170829120019



Erlotinib: A Targeted Anticancer Drug

Volume:13   Issue: 1
Pp: 3-16
Parijat Pandey and Harish Dureja*
DOI: 10.2174/1573394713666170522181615




Cancer and Treatment Modalities

Volume:13   Issue: 1
Pp: 17-27
Elham Hosseinzadeh, Nooshin Banaee* and Hassan Ali Nedaie
DOI: 10.2174/1573394713666170531081818




Phenothiazines and Related Drugs as Multi Drug Resistance Reversal Agents in Cancer Chemotherapy Mediated by p-glycoprotein

Volume:13   Issue: 1
Pp: 28-42
Ravinesh Mishra*, Swati Sareen, Bhartendu Sharma, Shubham Goyal, Gurpreet Kaur, Sweta Bhardwaj, Anees A. Siddiqui, Asif Husain, Rajeev K. Singla, Mohd Rashid, Deepak Kumar, Bhawana Sati, Nishtha Shalmali and Rajiv Kumar
DOI: 10.2174/1573394713666170524122904




Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma

Volume:13   Issue: 1
Pp: 43-62
Ankita Maji, Sachin M and Dwaipayan Sen*
DOI: 10.2174/1573394713666170525144104




Targeted Nanosystems for Cancer Therapy

Volume:13   Issue: 1
Pp: 63-73
Ruhee Jain, Tahseen Khan, Sourabh Jain, Ashutosh Pal Jain and Aakanchha Jain*
DOI: 10.2174/1573394713666170622104347